De Sanctis, Vincenzo, et al. “The Use of Oral Glucose-Lowering Agents (GLAs) in β-Thalassemia Patients With Diabetes: Preliminary Data from a Retrospective Study of ICET-A Network: Oral Glucose-Lowering Agents (GLAs) in β-Thalassemia Patients”. Acta Biomedica Atenei Parmensis, vol. 93, no. 2, May 2022, p. e2022162, https://doi.org/10.23750/abm.v93i2.12056.